Amalgamated Bank’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.2M Sell
23,478
-507
-2% -$62.3K 0.02% 627
2026
Q1
$2.83M Buy
23,985
+336
+1% +$46.9K 0.02% 654
2025
Q4
$3.88M Sell
23,649
-636
-3% -$99.6K 0.03% 521
2025
Q3
$3.25M Buy
24,285
+143
+0.6% +$17.4K 0.02% 604
2025
Q2
$3M Sell
24,142
-4
-0% -$509 0.02% 628
2025
Q1
$3.07M Sell
24,146
-968
-4% -$149K 0.03% 587
2024
Q4
$3.62M Buy
25,114
+238
+1% +$34.1K 0.03% 542
2024
Q3
$3.7M Sell
24,876
-1,740
-7% -$250K 0.03% 530
2024
Q2
$3.35M Sell
26,616
-2,203
-8% -$345K 0.03% 629
2024
Q1
$5.3M Sell
28,819
-5,536
-16% -$1.05M 0.05% 428
2023
Q4
$6.18M Sell
34,355
-1,769
-5% -$275K 0.05% 372
2023
Q3
$5.74M Buy
36,124
+134
+0.4% +$21.9K 0.05% 371
2023
Q2
$5.09M Sell
35,990
-2,097
-6% -$336K 0.04% 423
2023
Q1
$6.41M Sell
38,087
-1,956
-5% -$349K 0.05% 324
2022
Q4
$6.78M Buy
40,043
+62
+0.2% +$11.2K 0.06% 315
2022
Q3
$7.48M Buy
39,981
+1,395
+4% +$294K 0.07% 249
2022
Q2
$6.27M Sell
38,586
-414
-1% -$65.5K 0.06% 306
2022
Q1
$7.34M Sell
39,000
-120
-0.3% -$22.8K 0.06% 309
2021
Q4
$10.4M Buy
39,120
+1,408
+4% +$379K 0.08% 217
2021
Q3
$10.9M Sell
37,712
-3,839
-9% -$985K 0.09% 186
2021
Q2
$8.29M Buy
41,551
+31,074
+297% +$6.03M 0.07% 283
2021
Q1
$2.04M Sell
10,477
-525
-5% -$108K 0.08% 236
2020
Q4
$2.11M Buy
11,002
+45
+0.4% +$8.19K 0.08% 216
2020
Q3
$1.62M Sell
10,957
-292
-3% -$41.7K 0.07% 263
2020
Q2
$1.39M Buy
11,249
+1,521
+16% +$179K 0.06% 283
2020
Q1
$939K Sell
9,728
-249
-2% -$24K 0.02% 647
2019
Q4
$923K Buy
9,977
+925
+10% +$77.7K 0.02% 828
2019
Q3
$694K Buy
9,052
+185
+2% +$16.2K 0.01% 893
2019
Q2
$762K Buy
8,867
+2,573
+41% +$175K 0.02% 870
2019
Q1
$372K Buy
6,294
+145
+2% +$8.34K 0.01% 1142
2018
Q4
$324K Buy
+6,149
New +$361K 0.01% 1130
2018
Q3
Sell
-6,343
Closed -$298K 1589
2018
Q2
$298K Buy
+6,343
New +$261K 0.01% 1324

Other funds holding RGEN

Amalgamated Bank's RGEN Position: Q2 2026 in Review

Amalgamated Bank reduced its Repligen (RGEN) stake by 2.1% in Q2 2026, selling an estimated $62.3K and leaving 23,478 shares worth $3.2M. The position accounts for 0.02% of the portfolio, ranked #627.

Amalgamated Bank first reported a position in RGEN in Q2 2018 and has held it in 32 quarters since. The position peaked at $10.9M in Q3 2021. 215 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Amalgamated Bank held 23,478 shares of Repligen worth $3.2M as of Q2 2026.
  • Amalgamated Bank sold 507 Repligen shares in Q2 2026, an estimated $62.3K.
  • Repligen made up 0.02% of Amalgamated Bank's portfolio in Q2 2026, its #627 holding.
  • Amalgamated Bank first reported a position in Repligen in Q2 2018 and has held it in 32 quarters since.
  • Amalgamated Bank's Repligen position peaked at $10.9M in Q3 2021.
  • 215 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.